Fedak D - Search Results

1

[Myocardial dysfunction, neuropathy and nephropathy in long standing type 1 diabetic patients].

Galicka-Latała D, Konduracka E, Kuźniewski M, Fedak D, Sieradzki J. Galicka-Latała D, et al. Among authors: fedak d. Przegl Lek. 2005;62(12):1451-4. Przegl Lek. 2005. PMID: 16786771 Polish.

2

[Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].

Galicka-Latała D, Fedak D, Kuźniewski M, Kawalec E, Solnica B. Galicka-Latała D, et al. Among authors: fedak d. Przegl Lek. 2004;61(3):155-8. Przegl Lek. 2004. PMID: 15518324 Polish.

3

[Fetuin A and matrix GLA protein in long standing type I diabetic patients without ischaemic heart disease].

Galicka-Latała D, Kuźniewski M, Fedak D, Konduracka E, Sieradzki J. Galicka-Latała D, et al. Among authors: fedak d. Przegl Lek. 2006;63(12):1252-5. Przegl Lek. 2006. PMID: 17642133 Polish.

4

[The relationship between serum soluble apoptosis marker (sTRAIL) concentration and nutritional parameters in hemodialyzed patients].

Wyrwicz-Zielińska G, Fedak D, Kuźniewski M, Pawlica D, Kuśnierz-Cabala B, Solnica B, Janda K, Sułowicz W. Wyrwicz-Zielińska G, et al. Among authors: fedak d. Przegl Lek. 2013;70(7):427-30. Przegl Lek. 2013. PMID: 24167941 Polish.

5

[Undercarboxylated osteocalcin (Glu-OC) bone metabolism and vascular calcification in hemodialyzed patients].

Bentkowski W, Kuźniewski M, Fedak D, Dumnicka P, Kuśnierz-Cabala B, Janda K, Sułowicz W. Bentkowski W, et al. Among authors: fedak d. Przegl Lek. 2013;70(9):703-6. Przegl Lek. 2013. PMID: 24455828 Clinical Trial. Polish.

6

[Uromodulin - can it be a new marker of kidney damage?].

Fugiel A, Kuzniewski M, Fedak D. Fugiel A, et al. Among authors: fedak d. Przegl Lek. 2013;70(11):976-82. Przegl Lek. 2013. PMID: 24697042 Review. Polish.

7

Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.

Konduracka E, Galicka-Latala D, Cieslik G, Rostoff P, Fedak D, Sieradzki J, Naskalski J, Piwowarska W. Konduracka E, et al. Among authors: fedak d. Diabetes Obes Metab. 2008 Sep;10(9):719-25. doi: 10.1111/j.1463-1326.2007.00798.x. Epub 2007 Oct 15. Diabetes Obes Metab. 2008. PMID: 17941871 Clinical Trial.

8

Relationship between fetuin-A, bone turnover and inflammatory markers concentrations in serum of maintenance hemodialyzed patients.

Fedak D, Kuźniewski M, Dumnicka P, Kapusta M, Chmiel G, Solnica B, Sułowicz W. Fedak D, et al. Przegl Lek. 2016;73(11):799-804. Przegl Lek. 2016. PMID: 29693340

9

[Oxidative stress and its significance in prostate diseases].

Pilch P, Pilch W, Maciukiewicz P, Malik L, Kuźniewski M, Fedak D. Pilch P, et al. Among authors: fedak d. Przegl Lek. 2012;69(12):1297-301. Przegl Lek. 2012. PMID: 23750443 Review. Polish.

10

Effect of hemodialysis on acid leukocyte-type ribonuclease, alkaline ribonuclease and polymorphonuclear elastase serum levels in patients with end-stage renal disease.

Naskalski JW, Kapusta M, Fedak D, Dumnicka P, Kuśnierz-Cabala B, Kuźniewski M, Sułowicz W. Naskalski JW, et al. Among authors: fedak d. Nephron Clin Pract. 2009;112(4):c248-54. doi: 10.1159/000224791. Epub 2009 Jun 16. Nephron Clin Pract. 2009. PMID: 19546584 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters